摘要:
A congestive heart failure monitor has an impedance measuring unit that measures the impedance between at least two electrodes implanted in a patient, to use a detected change of the measured impedance as an indication of a change in the left atrium volume. Any analyzing unit analyzes the measured impedance and detects insipient congestive heart failure dependent on a quotient of a maximum value of the measured impedance and a minimum value of the measured impedance during a cardiac cycle.
摘要:
In an implantable heart stimulating device, system and method, electrical stimulation pulses are delivered to first and second ventricles of a heart with a variable time interval therebetween, and signals are sensed at two different positions in the heart, from which an impedance value is derived. A minimum value and a maximum value of the impedance value are determined during a heart cycle, and a relationship between the minimum and maximum values also is determined. The time interval is varied and the relationship is monitored over a number of heart cycles. The time interval is set so that the relationship satisfies a predetermined requirement.
摘要:
An implantable medical apparatus for detecting diastolic heart failure, DHF, has a DHF determining device for determining at least one DHF parameter for detecting a DHF state of the heart of a patient. The DHF includes circuitry for determining, as the DHF parameter, the time duration of a predetermined phase of diastole. A pacemaker has such an apparatus and a control unit that optimizes pacing therapy and pacemaker settings depending on the determined time duration. A corresponding method of detecting diastolic heart failure, DHF, includes determining at least one DHF parameter for detecting a DHF state of the heart of a patient. As the DHF parameter, the time duration of a predetermined phase of diastole is determined.
摘要:
An implantable medical apparatus for detecting diastolic heart failure, DHF, has a DHF determining device for determining at least one blood pressure parameter for detecting a DHF state of the heart of a patient. The DHF determining device includes a pressure measuring unit for measuring pulse pressure in a cardiac cycle for a predetermined workload situation of the patient as the blood pressure parameter, and a comparator compares the measured pulse pressure with a predetermined reference value. A pacemaker includes such an apparatus and a control unit that optimizes pacing therapy depending on the result of the comparison of the measured pulse pressures with the predetermined reference values. A corresponding method of detecting diastolic heart failure, DHF, includes the step of determining at least one blood pressure parameter for detecting a DHF state of the heart of a patient by determining, as said blood pressure parameter, the pulse pressure in a cardiac cycle for a predetermined workload situation of the patient, and the determined pulse pressure is compared with a predetermined reference value.
摘要:
In a device and method for evaluating positions of a medical lead during an implantation procedure, an IEGM signal and a signal indicative of heart pumping activity are obtained for each of a number of different lead positions, and those signals are stored dependent on the different lead positions. A processor automatically determines a lead position, from among the stored lead positions, that results in most favorable hemodynamics of the heart, based on the IEGM signal and the pumping activity signal.
摘要:
In an implantable medical device and a method for monitoring ventricular synchronicity of a heart, impedance signals are measured that reflect septal wall movements and impedance amplitude peaks in the impedance signal are detected. A synchronicity index indicating a degree of synchronicity is determined based on detected impedance peaks, with at least two impedance peaks detected within a predetermined time window including a cardiac cycle or a part of a cardiac cycle indicating an increased dyssynchronicity in the ventricular contractions.
摘要:
A biocompatible medical implant has at least one part thereof composed of ceramic material with the formula NaxKyNbO3, wherein 0≦x≦0.8, 0.2≦y≦1, and x+y=1. The ceramic material can be polarized to give the implant spatially varying piezoelectric properties. Signals can be measured from the respective piezoelectric regions of the selectively polarized ceramic material to provide an indication of the degree of fixation of the implant to surrounding tissue.
摘要翻译:生物相容性医用植入体至少有一部分由具有式NaxKyNbO3的陶瓷材料构成,其中0≤x≤0.8,0.2≤y≤1且x + y = 1。 陶瓷材料可以被极化以给予植入物空间上变化的压电性质。 可以从选择性极化的陶瓷材料的各个压电区域测量信号,以提供植入物到周围组织的固定程度的指示。
摘要:
A method for producing a biocompatible material of the formula NaxKyNbO3, 0≦x≦0.8, 0.2≦y≦1, x+y=1 includes the steps of a) providing a Na-precursor and a K-precursor for NaxKyNbO3, b) mixing the precursors in solution wherein said precursors first react to form a sol and thereafter a gel, c) heat treating the gel to obtain an oxide of the material NaxKyNbO3, 0≦x≦0.8, 0.2≦y≦1, x+y=1. The material can be produced as a film, and the material or film can be provided on the exterior surface of a medical implant that will come into contact with body tissue and/or body fluids upon implantation thereof.
摘要翻译:一种制备式NaxKyNbO3,0 <= x <= 0.8,0.2 <= y <= 1,x + y = 1的生物相容性材料的方法包括以下步骤:a)提供Na-前体和K-前体, NaxKyNbO3,b)在溶液中混合前体,其中所述前体首先反应形成溶胶,然后凝胶,c)热处理该凝胶以获得材料NaxKyNbO3的氧化物,0≤x≤0.8,0.2≤y <= 1,x + y = 1。 该材料可以作为膜制造,并且材料或膜可以设置在将在其植入时将与身体组织和/或体液接触的医用植入物的外表面上。